Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
234 | 3 | GYNECOLOGIC ONCOLOGY//GYNECOL ONCOL//OVARIAN CANCER | 48422 |
1441 | 2 | CA 125//CA 19 9//HE4 | 8114 |
12516 | 1 | ANTI P53 ANTIBODIES//SERUM P53 ANTIBODY//P53 ANTIBODIES | 931 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ANTI P53 ANTIBODIES | authKW | 954425 | 4% | 83% | 34 |
2 | SERUM P53 ANTIBODY | authKW | 812427 | 3% | 100% | 24 |
3 | P53 ANTIBODIES | authKW | 677811 | 3% | 69% | 29 |
4 | P53 AUTOANTIBODIES | authKW | 476030 | 2% | 94% | 15 |
5 | AUTOANTIBODIES | authKW | 289350 | 26% | 4% | 243 |
6 | SERPA | authKW | 210913 | 1% | 69% | 9 |
7 | ANTI P53 | authKW | 207336 | 1% | 88% | 7 |
8 | HENAN TUMOR EPIDEMIOL | address | 187470 | 1% | 46% | 12 |
9 | ONCIMMUNE LTD | address | 152327 | 1% | 75% | 6 |
10 | ANTI P53 AUTOANTIBODIES | authKW | 141045 | 1% | 83% | 5 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 8126 | 49% | 0% | 452 |
2 | Biochemical Research Methods | 1293 | 13% | 0% | 122 |
3 | Medical Laboratory Technology | 423 | 4% | 0% | 35 |
4 | Immunology | 364 | 11% | 0% | 103 |
5 | Gastroenterology & Hepatology | 196 | 5% | 0% | 47 |
6 | Medicine, Research & Experimental | 109 | 5% | 0% | 49 |
7 | Pathology | 59 | 3% | 0% | 27 |
8 | Respiratory System | 46 | 2% | 0% | 23 |
9 | Biotechnology & Applied Microbiology | 30 | 4% | 0% | 37 |
10 | Rheumatology | 16 | 1% | 0% | 10 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HENAN TUMOR EPIDEMIOL | 187470 | 1% | 46% | 12 |
2 | ONCIMMUNE LTD | 152327 | 1% | 75% | 6 |
3 | EXCELLENCE AUTOIMMUN CANC | 90267 | 0% | 67% | 4 |
4 | ORAL ONCOL GRP | 67702 | 0% | 100% | 2 |
5 | ONCOPROTE CLIN | 60930 | 0% | 60% | 3 |
6 | WM KECK AUTOIMMUNE DIS | 59749 | 2% | 13% | 14 |
7 | PROGRAM MOL BIOL HUMAN GENET | 44534 | 1% | 26% | 5 |
8 | TUMOR VACCINE GRP | 43096 | 1% | 12% | 11 |
9 | GYNECOL REPROD BIOL | 41657 | 0% | 31% | 4 |
10 | HARVARD PROTE | 38681 | 0% | 29% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROTEOMICS CLINICAL APPLICATIONS | 7904 | 2% | 2% | 15 |
2 | CANCER BIOMARKERS | 5521 | 1% | 1% | 11 |
3 | JOURNAL OF PROTEOME RESEARCH | 2820 | 2% | 0% | 23 |
4 | CANCER DETECTION AND PREVENTION | 2569 | 1% | 1% | 11 |
5 | PROTEOMICS | 1847 | 2% | 0% | 18 |
6 | TUMOR BIOLOGY | 1748 | 2% | 0% | 19 |
7 | BIOMARKERS | 1671 | 1% | 1% | 6 |
8 | INTERNATIONAL JOURNAL OF CANCER | 1646 | 3% | 0% | 32 |
9 | EXPERT REVIEW OF PROTEOMICS | 1571 | 1% | 1% | 6 |
10 | ANTICANCER RESEARCH | 1521 | 3% | 0% | 30 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTI P53 ANTIBODIES | 954425 | 4% | 83% | 34 | Search ANTI+P53+ANTIBODIES | Search ANTI+P53+ANTIBODIES |
2 | SERUM P53 ANTIBODY | 812427 | 3% | 100% | 24 | Search SERUM+P53+ANTIBODY | Search SERUM+P53+ANTIBODY |
3 | P53 ANTIBODIES | 677811 | 3% | 69% | 29 | Search P53+ANTIBODIES | Search P53+ANTIBODIES |
4 | P53 AUTOANTIBODIES | 476030 | 2% | 94% | 15 | Search P53+AUTOANTIBODIES | Search P53+AUTOANTIBODIES |
5 | AUTOANTIBODIES | 289350 | 26% | 4% | 243 | Search AUTOANTIBODIES | Search AUTOANTIBODIES |
6 | SERPA | 210913 | 1% | 69% | 9 | Search SERPA | Search SERPA |
7 | ANTI P53 | 207336 | 1% | 88% | 7 | Search ANTI+P53 | Search ANTI+P53 |
8 | ANTI P53 AUTOANTIBODIES | 141045 | 1% | 83% | 5 | Search ANTI+P53+AUTOANTIBODIES | Search ANTI+P53+AUTOANTIBODIES |
9 | TUMOR ASSOCIATED ANTIGEN | 140108 | 5% | 8% | 51 | Search TUMOR+ASSOCIATED+ANTIGEN | Search TUMOR+ASSOCIATED+ANTIGEN |
10 | SEREX | 125994 | 2% | 17% | 22 | Search SEREX | Search SEREX |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |